Diabetes increases the risk of bone fracturesFriday, 12 June 2020
The research, led by the University of Sheffield, concluded that people with type 1 and type 2 diabetes have an increased risk of suffering hip and non-vertebral fractures (those not occurring in the spine or skull).
The findings, show people with type 1 diabetes are at greater risk than people with type 2 diabetes, however insulin use and length of time someone has lived with the condition further increased the risk for people with type 2 diabetes.
Diabetes has a number of widely-known complications, however this study highlights the impact of the condition on bone health – specifically fractures.
Lead researcher Dr Tatiane Vilaca, from the University of Sheffield, said: “Diabetes can cause a number of well-known complications including kidney problems, loss of eyesight, problems with your feet and nerve damage. However, until now many people with diabetes and their doctors are unaware that they are also at greater risk of bone fractures.
“We need to raise awareness about the greater risk people with diabetes face to help them to prevent fractures. For example, preventing falls can reduce their risk of fracture.
“Fractures can be very serious, especially in older people. Hip fractures are the most severe as they cause such high disability. Around 76,000 people in the UK suffer a hip fracture every year and it is thought as many as 20 percent of people will die within a year of the fracture. Many others don’t fully regain mobility, and for many people it can cause a loss of independence.”
Diagnosing the risk
Professor Richard Eastell, from the University of Sheffield’s Mellanby Centre for Bone Research, said: “This important research highlights the urgent need for doctors to evaluate the risk of fracture for patients with diabetes and also to look at potential treatments which may help to reduce that risk.
“We hope that by raising awareness about the greater risk people with diabetes face, bone density and bone strength will become something that doctors assess routinely in patients with the condition in the same way they do currently for other well-known complications.”